Our Medicines - Serving Patients
We are proud to offer innovative prescription and non-prescription medicines for a wide range of conditions.
The following are the products of Boehringer Ingelheim (Canada) Ltd./Ltée. The information contained in the links is intended for Canadian healthcare professionals and patients.
Our Products
| Brand Name | Product Monograph | Consumer Information |
| Aggrenox | Download | Download |
| Aptivus | Download | Download |
| Atrovent HFA | Download | Download |
| Basaglar | Download | Download |
| Combivent Respimat | Download | Download |
| Combivent UDV | Download | Download |
| Flomax CR | Download | Download |
| Giotrif | Download | Download |
| Glyxambi | Download | Download |
| Inspiolto Respimat | Download | Download |
| Jardiance | Download | Download |
| JentaDueto | Download | Download |
| Micardis | Download | Download |
| Micardis Plus | Download | Download |
| Mirapex | Download | Download |
| Mobicox | Download | Download |
| Ofev | Download | Download |
| Persantine | Download | Download |
| Pradaxa (New Name) | Download | Download |
| Praxbind | Download | Download |
| Spiriva | Download | Download |
| Spiriva Respimat | Download | Download |
| Striverdi Respimat | Download | Download |
| Synjardy | Download | Download |
| Trajenta | Download | Download |
| Twynsta | Download | Download |
| Viramune | Download | Download |
Medications Return Programs
For more information and to locate a safe disposal drop-off location near you, visit www.healthsteward.ca
Important information regarding Pradaxa® (dabigatran etexilate)
| November 2011 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
| December 2012 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
| March 2012 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
Important information regarding Ofev® (nintedanib)
| January 2018 | |
| Dear Healthcare Professionnal Letter | View document |